Listen in as Jonathan A. Bernstein, MD, and Ryan Haumschild, PharmD, MS, MBA, CPEL, discuss approaches to managing systemic mastocytosis—from earlier recognition and diagnosis to the use of emerging targeted therapies—that can reduce disease burden and improve outcomes for patients.